ArticleFrontiers in oncology2026
A case report: long-term survival cases of nasopharyngeal carcinoma with breast metastasis.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metastatic malignancies in the breast most commonly originate from cancers of adjacent organs, including lymphoma, melanoma, and lung cancers, while metastases from distant primary sites, including gastrointestinal, head and neck, and pelvic malignancies, are less likely to metastasize to the breast. Nasopharyngeal carcinoma (NPC) with breast metastases is rare. This report describes a patient with pathologically confirmed NPC with breast metastasis who achieved favorable treatment outcomes. Case presentation: A 50-year-old Chinese man with a history of NPC developed multiple systemic metastases. Histopathological examination of a breast lesion confirmed NPC metastasis. After systemic chemotherapy combined with immunotherapy, the patient achieved disease remission and was alive at the time of reporting. Conclusion: This case also serves as a reminder of the importance of re-biopsy for recurrent or metastatic lesions. These observations emphasize the need for further research regarding uncommon metastatic patterns of NPC to refine treatment strategies and improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.